eFFECTOR Therapeutics, Inc.
EFTR
$0.0002
$0.000.00%
OTC PK
03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 25.38M | 18.37M | 17.78M | 25.02M | 19.01M |
Total Receivables | 17.00K | 52.00K | 23.00K | 72.00K | 42.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 850.00K | 1.42M | 1.48M | 884.00K | 1.85M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 26.25M | 19.84M | 19.28M | 25.98M | 20.89M |
|
|||||
Total Current Assets | 26.25M | 19.84M | 19.28M | 25.98M | 20.89M |
Net Property, Plant & Equipment | 415.00K | 193.00K | 312.00K | 299.00K | 311.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 466.00K | 513.00K | 567.00K | 615.00K | 723.00K |
Total Assets | 27.13M | 20.54M | 20.16M | 26.89M | 21.93M |
|
|||||
Total Accounts Payable | 1.71M | 2.33M | 1.14M | 1.45M | 3.79M |
Total Accrued Expenses | 3.79M | 2.92M | 1.98M | 1.92M | 2.08M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 20.07M | 20.55M | 20.47M | 20.39M | 20.30M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 473.00K |
Total Other Current Liabilities | -- | -- | -- | -- | 473.00K |
Total Current Liabilities | 25.57M | 25.80M | 23.59M | 23.76M | 26.65M |
|
|||||
Total Current Liabilities | 25.57M | 25.80M | 23.59M | 23.76M | 26.65M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 179.00K | -- | 6.00K | 25.00K | 43.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 556.00K | 543.00K | 533.00K | 530.00K | 46.00K |
Total Liabilities | 26.30M | 26.34M | 24.13M | 24.31M | 26.74M |
|
|||||
Common Stock & APIC | 189.04M | 173.58M | 166.28M | 164.52M | 148.77M |
Retained Earnings | -188.21M | -179.38M | -170.25M | -161.94M | -153.58M |
Treasury Stock & Other | -- | -- | -1.00K | 1.00K | 1.00K |
Total Common Equity | 827.00K | -5.80M | -3.97M | 2.58M | -4.81M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 827.00K | -5.80M | -3.97M | 2.58M | -4.81M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 827.00K | -5.80M | -3.97M | 2.58M | -4.81M |
|